Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Lovestone

Showing results (31-40 of 333) with videos related to

Pageof 34
Sort By:
Neuroscience Letters|April 4, 2006
TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanismClaudie Hooper, Richard Killick, Mahvash Tavassoli, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 11, 2004
Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in late-life depressionJorge Cervilla, Martin Prince, Suzanne Joels, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
Depression in Alzheimer's disease: the effect of serotonin receptor gene variationClive Holmes, Maria Arranz, David Collier, et al.
The Lancet. Neurology|July 28, 2015
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directionsSandrine Andrieu, Nicola Coley, Simon Lovestone, et al.
Electrophoresis|March 17, 2009
A proposed metabolic strategy for monitoring disease progression in Alzheimer's diseaseNicola Greenberg, Antonio Grassano, Madhav Thambisetty, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2019
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medicationsDavid M Kern, M Soledad Cepeda, Simon Lovestone, et al.
Genome Medicine|June 30, 2018
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's diseaseLaura M Winchester, John Powell, Simon Lovestone, et al.
International Psychogeriatrics|April 20, 2013
Smell identification function as a severity and progression marker in Alzheimer's diseaseLatha Velayudhan, Megan Pritchard, John F Powell, et al.
Clinical Drug Investigation|July 22, 2019
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug DiscoveryM Soledad Cepeda, David M Kern, Guy R Seabrook, et al.
Frontiers in Neurology|July 13, 2013
The importance of tau phosphorylation for neurodegenerative diseasesWendy Noble, Diane P Hanger, Christopher C J Miller, et al.
Pageof 34

Showing results (31-40 of 333) with videos related to

Sort By:
Pageof 34
Neuroscience Letters|April 4, 2006
TAp73alpha induces tau phosphorylation in HEK293a cells via a transcription-dependent mechanismClaudie Hooper, Richard Killick, Mahvash Tavassoli, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|March 11, 2004
Genes related to vascular disease (APOE, VLDL-R, DCP-1) and other vascular factors in late-life depressionJorge Cervilla, Martin Prince, Suzanne Joels, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|April 23, 2003
Depression in Alzheimer's disease: the effect of serotonin receptor gene variationClive Holmes, Maria Arranz, David Collier, et al.
The Lancet. Neurology|July 28, 2015
Prevention of sporadic Alzheimer's disease: lessons learned from clinical trials and future directionsSandrine Andrieu, Nicola Coley, Simon Lovestone, et al.
Electrophoresis|March 17, 2009
A proposed metabolic strategy for monitoring disease progression in Alzheimer's diseaseNicola Greenberg, Antonio Grassano, Madhav Thambisetty, et al.
Alzheimer'S & Dementia (New York, N. Y.)|December 25, 2019
Aiding the discovery of new treatments for dementia by uncovering unknown benefits of existing medicationsDavid M Kern, M Soledad Cepeda, Simon Lovestone, et al.
Genome Medicine|June 30, 2018
Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's diseaseLaura M Winchester, John Powell, Simon Lovestone, et al.
International Psychogeriatrics|April 20, 2013
Smell identification function as a severity and progression marker in Alzheimer's diseaseLatha Velayudhan, Megan Pritchard, John F Powell, et al.
Clinical Drug Investigation|July 22, 2019
Comprehensive Real-World Assessment of Marketed Medications to Guide Parkinson's Drug DiscoveryM Soledad Cepeda, David M Kern, Guy R Seabrook, et al.
Frontiers in Neurology|July 13, 2013
The importance of tau phosphorylation for neurodegenerative diseasesWendy Noble, Diane P Hanger, Christopher C J Miller, et al.
Pageof 34